The turnover of cardiomyocytes in the aging female and male heart is currently unknown, emphasizing the need to define human myocardial biology.
dating of cells, has claimed that Ϸ1% and Ϸ0.45% replacement of myocytes occurs annually in the human heart at 25 and 75 years of age, respectively. 8 These findings indicate that only 50% of myocytes are renewed during the entire life of the human heart, from birth to death, whereas an equal number lives as long as the organ and organism, up to 100 years of age and longer. Although the possibility of myocyte regeneration was confirmed, the actual magnitude of the process is in contrast with the level of myocyte apoptosis found in the adult human heart 9 and the progressive increase in myocyte loss that occurs with aging in humans. 10 Therefore, we determined the interaction of myocyte regeneration, cellular senescence, growth inhibition, and apoptosis in normal female and male human hearts, collected from patients 19 to 104 years of age who died from causes other than cardiovascular diseases. A large number of hearts was included to obtain a common denominator of the processes that regulate replication and death of ventricular myocytes. The average age of cardiomyocytes, their age distribution, turnover rate, and time to acquire the senescent phenotype were measured to define the biology of myocardial aging as a function of organ and organism lifespan.
Methods
The percentage of senescent myocytes and the fraction of cells undergoing apoptosis were evaluated by the expression of p16 INK4a and terminal deoxynucleotidyl transferase labeling, respectively. The number of cycling and dividing myocytes was assessed by Ki67 and phosphorylated histone-3 (phospho-H3)/aurora B kinase.
An expanded Methods section is available in the Online Data Supplement at http://circres.ahajournals.org.
Results

Physiological Myocardial Aging
In an attempt to avoid the effects of causes unrelated to the aging process, a series of variables were considered in the selection of the 74 human hearts studied. A stringent approach was followed to minimize the consequences on myocardial aging of unpredictable events that occur during the course of life together with the pathological manifestations of the heart and other organs. 10 These factors confound the etiology of the aging myopathy and its evolution. Therefore, specific selection criteria were introduced clinically, anatomically, and histologically (Online Table  I ). The latter was particularly relevant, because multiple focal areas of myocardial damage and tissue fibrosis, indicative of extensive myocyte loss, are not detectable grossly and are frequently associated with an apparently normal cardiac weight, resulting from reactive hypertrophy of the remaining viable myocytes.
Cardiac aging was characterized by modest interstitial and perivascular fibrosis, occasional small foci of reparative fibrosis and lack of inflammatory infiltrates (Online Figure I , A through F). A certain degree of myocyte hypertrophy was present in the male myocardium, whereas, in the female heart, cellular enlargement became apparent only in the advanced stages of life (Online Figure I, G through J). In both genders, the aging heart had relatively intact coronary arteries or modest atherosclerosis, with reductions in luminal diameter, known not to affect blood flow or coronary vascular resistance. 11
Women and Men
The predominant cause of death in our patient population was pulmonary infection, followed by rupture of cerebral and aortic aneurisms, traumatic injury, pulmonary thromboembolism, suicide, and gastrointestinal hemorrhage (Online Table II ). Other noncardiovascular illnesses were also involved in a few cases. In the majority of patients, death occurred as a result of a disease state, but pathology developed terminally and had, at most, little effect on the myocardium. When acute trauma was the fatal event, a complete medical history could not be obtained. However, the absence of a previous hospital record, and the lack of organ pathology at complete autopsy, which was confirmed by detailed histology, justified their inclusion in the study.
Thirty-two female and 42 male hearts were analyzed (Online Table II ). From 19 to 49 years of age, 28 hearts were obtained, and a similar number of cases (nϭ24) encompassed the age interval from 50 to 69 years. From 72 to 104 years, 22 cases were collected. Male hearts were more numerous at a younger age, whereas, from 80 to 104 years, the number of female hearts (nϭ11) was nearly twice the number of male hearts (nϭ6). This difference may reflect the longer lifespan of women in the Western world.
Earlier quantitative studies of the aging human heart in women and men 10 have shown that from 17 to 89 years of age, nearly 64ϫ10 6 cardiomyocytes are lost per year in men, whereas myocyte number does not change in the female heart up to 90 years of age. These observations have raised the question of whether these remarkable differences in the aging-dependent adaptation of the myocardium according to gender reflect distinct degrees of myocyte turnover. A perfect balance appears to exist between myocyte renewal and death in women, whereas myocyte loss exceeds cell formation in men. Alternatively, myocyte turnover is extremely low in the female heart, being essentially undetectable by morphometric protocols. Therefore, the critical determinants of cardiac homeostasis, ie, ongoing myocyte death and regeneration, were measured in the aging heart of both sexes to define the characteristics of the myocardium at the time of death of the patient.
Myocyte Senescence and Death
In the human heart, apoptosis is invariably coupled with the expression of the aging-associated protein p16 INK4a that is a marker of replicative senescence and irreversible growth arrest of progenitor cells in various organs including the heart. [12] [13] [14] P16 INK4a -positive myocyte nuclei were found at all ages in women and men (Online Figure II , A through D); the specificity of the recorded signal was validated by spectral analysis (Online 
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Figure II, E). The frequency of senescent myocytes was commonly higher in men than in women throughout life. In the oldest man (104 years of age), 80% of myocytes expressed this nuclear protein. This was not the case in the oldest woman (102 years of age), in whom a relevant proportion of myocytes, 45%, did not reach the senescent phenotype. From 19 to 49, 50 to 69, and 72 to 104 years of age, the fraction of myocyte nuclei labeled by p16 INK4a was 43%, 35%, and 32% lower in women than in men, respectively ( Figure 1A ). From 19 to 104 years of age, the time-dependent increase in old myocytes was 0.68% per year in women and 0.89% per year in men; the 31% higher rate of accumulation of senescent myocytes in the aging male heart was significant ( Figure 1B ). In comparison with cellular senescence, myocyte apoptosis was relatively low, but it occurred only in p16 INK4a -positive cells (Online Figure II, F and G). Cell death was higher in men than in women at 19 to 49, 50 to 69, and 72 to 104 years of age ( Figure 1C ). However, the rate of increase in myocyte apoptosis with age did not differ with gender: 131 cells/10 8 per year in men and 123 cells/10 8 per year in women ( Figure 1D ).
Cell apoptosis is completed in all organs in less than 4 hours, 15 suggesting that these rates of cell death result in a massive loss of myocytes with aging. If we consider the number of cells present in the left ventricle (LV) in women and men at 20 years, 10 the myocardium would essentially disappear with time. In the absence of myocyte formation, only 5% of cardiomyocytes would persist at 63 and 48 years of age in women and men, respectively ( Figure 1E ). Thus, myocyte regeneration has to play a major role in the preservation of tissue mass and function of the aging human heart.
Aging and hCSCs
The possibility that a certain degree of myocyte regeneration occurs in the human heart is currently accepted, but questions persist concerning the origin of newly formed cardiomyocytes. The mammalian heart contains a pool of c-kit-positive cells, which possess the fundamental properties of stem cells: they are self-renewing, clonogenic, and multipotent in vitro and in vivo. 3, 6, 7, 12, 16 These findings point to resident stem cells as the source of myocyte renewal physiologically and pathologically. Studies in rodents have claimed that terminally differentiated myocytes can be forced to reenter the cell cycle and divide. [17] [18] [19] However, this work fell short in documenting whether a mature myocyte, Ϸ25 000 m 3 in volume, increases its size during S phase and G 2 phase, reaching Ϸ50 000 m 3 volume, and then divides giving rise to 2 daughter cells Ϸ25 000 m 3 each. Conversely, dividing myocytes are small poorly differentiated cells, resembling cycling amplifying myocytes in the process of acquiring the adult postmitotic phenotype. 20 Genetic manipulations involving transgene constructs placed under the control of the ␣-myosin heavy chain promoter 17, 18 inevitably affect myocyte precursors and the pool of amplifying myocytes. 21 Collectively, these observations support the notion that myocyte regeneration in the human heart is dictated by activation and commitment of resident hCSCs and a hierarchical organization of their progeny. According to this model of myocyte renewal, the acquisition of the myocyte phenotype involves sequentially the generation of myocyte progenitors and precursors, cycling amplifying myocytes, and, ultimately, mature postmitotic parenchymal cells. 3, 6, 7, 16, 20 The quantitative assessment of this process requires the analysis of its various components (Online Figure III myocytes are no longer positive for c-kit, and sarcomeres progressively accumulate. This cell class proliferates and concurrently differentiates until the adult cell phenotype is reached, and cell division is permanently suppressed. 3, 6, 7, 16, 20 The number of hCSCs was similar in the young female and male myocardium but differed in the middle-aged and old heart ( Figure 2A ). In women, from 21 to 102 years of age, hCSCs increased at a rate of 2300/10 g per year, whereas, in men, from 19 to 104 years of age, hCSCs increased at a rate of 1400/10 g per year. This difference was statistically significant ( Figure 2B ). These values, however, do not consider the biological properties of hCSCs. Three variables dictate the number of functionally competent hCSCs in the myocardium: (1) degree of cell replication; (2) length of the cell cycle; and (3) proportion of cells that have the ability to divide or have acquired the senescent phenotype.
The cell cycle marker Ki67 was used to measure the fraction of proliferating hCSCs, because this nuclear protein is coupled with karyokinesis and cytokinesis. 3, 12 Comparable values were found in young hearts of both genders, whereas differences between women and men became apparent with age. Ki67-positive hCSCs increased 514/10 6 per year in women and 193/10 6 per year in men ( Figure 2C and 2D; Online Figure IV); the 2.7-fold higher yearly rate of hCSC growth in women was significant.
The length of the cell cycle was determined in vitro in hCSCs obtained from the right atrial appendage of 4 patients (2 men [age: 56 and 83 years] and 2 women [age: 50 and 72 years]), who underwent coronary bypass surgery. hCSCs were pulse-labeled with bromodeoxyuridine (BrdUrd) for 20 minutes, and cells were fixed at 1-hour intervals, up to 48 hours, to assess the percentage of labeled mitosis. 22 This parameter was derived from a total of 1041 hCSCs in mitosis and plotted as a function of time. The duration of the cell cycle was comparable in the 4 determinations and averaged 26Ϯ4 hours ( Figure 2E ). Senescent hCSCs were identified by the expression of p16 INK4a . 13 This nuclear protein was detected more frequently in male than in female hCSCs at all ages ( Figure 3A and 3B). However, the time-dependent increase in the rate of p16 INK4apositive hCSCs did not differ in the female and male heart ( Figure 3C ). Because the percentage of Ki67-positive cycling hCSCs and the duration of the cell cycle were similar in women and men, the number of hCSCs and the fraction of p16 INK4a -negative cells were combined to yield the pool of functionally competent hCSCs in the aging heart. Contrary to expectation, this variable increased in the old and senescent myocardium, although these changes were more dramatic in women than men ( Figure 3D and 3E).
Aging and hCSC Differentiation
The compartment of myocyte progenitors and precursors increased as a function of age in both genders. Similar values were found in the young female and male heart, whereas the number of these cell classes together became progressively higher in women 50 years of age and older (Online Figure V , A). The rate of formation of myocyte progenitors and precursors was 11 000/10 g per year in the female and 6700/10 g per year in the male myocardium (Online Figure V , B). Amplifying myocytes proliferate and accumulate structural proteins needed for their mechanical behavior and phenotypic maturation. Three markers were used to characterize their growth behavior: Ki67, phospho-H3, and aurora B kinase. Ki67 is expressed in late G 1 , S, G 2 and early mitosis and is not implicated in DNA repair. 23 Phospho-H3 is upregulated in late G 2 and mitosis. It is highly phosphorylated at Ser10 during chromatin condensation and remains phosphorylated up to the end of telophase. 24 Aurora B kinase is associated with separating chromosomes throughout mitosis, and it localizes at the cleavage furrow documenting cytokinesis. 25 Amplifying myocyte nuclei labeled by Ki67, phospho-H3, and aurora B kinase were found in young, middle-age, and senescent hearts ( Figure 4A Figure 4E ) were, respectively, 1.7-and 1.5-fold higher in old women than men, pointing to enhanced myocyte renewal in the female LV. Importantly, the rate of increase in amplifying (Online Figure V, D) and mitotic ( Figure  4F ) myocytes per year was higher in the female than male myocardium. In agreement with previous results, 26 the proportion of mononucleated and binucleated myocytes did not change from 19 to 104 years of age (Online Figure VI) . Thus, Ki67, phospho-H3, and aurora B kinase labeling were all markers of cell replication, indicating that cardiac aging was characterized by a significant degree of myocyte regeneration.
Aging and Postmitotic Myocytes
Young, nondividing myocytes were identified by the lack of expression of Ki67 and p16 INK4a . This myocyte class was The rate of increase in the fraction of p16 INK4a -positive hCSCs with age is similar in the female and male LV. D, The number of functionally competent hCSCs/10 g of LV is higher in women than men at all ages. E, The rate of increase in the number of functionally competent hCSCs/10 g of LV with age is higher in women than men. Age and gender are indicated in A.
consistently higher in women than men 50 years of age and older ( Figure 4G ). In both genders, an inverse relationship was found between young myocytes and aging. The rate of decrease of young myocytes was 0.69% per year in women and 0.89% per year in men, and this difference was significant ( Figure 4H ). When the rate of decrease in the fraction of young myocytes ( Figure 4H ) was compared with the rate of generation of senescent cells (see Figure 1B) , it became evident that activation and differentiation of hCSCs was insufficient to maintain the youth of the organ and, possibly, the structural integrity of the aging myocardium. The timedependent decrease in young postmitotic myocytes was In D, aurora B kinase is located in the 2 sets of telophase chromosomes and at the cleavage furrow of the dividing myocyte (arrowhead). Insets in A through D illustrate the organization of chromosomes in the dividing cells. E, With age, the fraction of myocytes positive for phospho-H3 increases more in women than men. F indicates female; M, male. *PϽ0.05 vs female. F, With age, the rate of increase of mitotic myocytes is higher in the female than in the male LV. G, The fraction of young nondividing myocytes decreases with age less in women than men. F indicates female; M, male. *PϽ0.05 vs female. H, The rate of decrease in the proportion of young nondividing myocytes with age is lower in females than males. The rate of increase in the fraction of amplifying (I) and mitotic (J) myocytes with age is higher in females than it is in males.
coupled with an age-dependent increase in senescent hCSCs (Online Figure VII) . However, this negative effect was more apparent in the male heart, which also lost a large number of parenchymal cells. 10 Conversely, the myocyte compartment is preserved in the old female heart. 10
Nuclear Ploidy and Cell Fusion
To strengthen the notion that dividing myocytes were actually the progeny of hCSCs, the presence of ploidy and cell fusion was determined by measuring, respectively, DNA content by confocal microscopy and the number of sex chromosomes by Q-FISH (quantitative fluorescence in situ hybridization). 3, 12, 14 These determinations were restricted to 10 young (5 female and 5 male) and 10 old (5 female and 5 male) hearts.
In the majority of cases, 2n diploid DNA content was found in all samples ( Figure 5A ). The fraction of myocyte nuclei with DNA content Ͼ2n and Ͻ4n reflected replicating cells expressing Ki67. Tetraploid and octaploid myocyte nuclei increased with age in both the female and male heart ( Figure 5B ). These polyploid cells were negative for Ki67, excluding that they represented cycling cells in G 2 . Additionally, myocyte nuclei contained almost exclusively 2 X chromosomes or 1 X and 1 Y chromosome, ruling out cell fusion ( Figure 5C ). Myocyte nuclei that contained 2 sets of sex chromosomes represented dividing cells positive for phospho-H3 ( Figure 5D ). Thus, forming myocytes were predominantly the descendants of hCSCs.
Hierarchical Organization of the Myocyte Progeny
Two independent mathematical models were introduced to determine the age and turnover of cardiomyocytes: the hierarchical and population dynamics models. 27, 28 The hierarchical model allows the characterization of the biological processes occurring at the level of the controlling cells, ie, the hCSCs, and their destiny following activation and differentiation. 27 By this approach, the number of cardiomyocytes generated by hCSCs in a specific time frame can be derived, together with their average age.
In both women and men, the magnitude of entry of hCSCs into the cell cycle was similar in the young and middle-aged heart: Ϸ2900 cells/10 g of myocardium per day in the young heart and Ϸ6500 cells/10 g of myocardium per day in the middle-aged heart. In the old heart, this value was significantly higher in women (17 000 cells/10 g of myocardium per day) than in men (9400 cells/10 g of myocardium per day) (Online Figure VIII, A) . There were no differences in the number of mature myocytes generated by 1 female or 1 male hCSC at each of the 3 age intervals examined (Online Figure  VIII, B ). However, in young, middle-aged, and old women and men, activation and differentiation of a single hCSC led to the generation of 36 (young), 41 (middle-aged), and 66 (old) mature myocytes in 5.6, 5.8, and 6.5 days, respectively. These values are dependent on the length of the cell cycle (see Figure 2E ) and the number of divisions required by hCSCs to complete before mature myocytes are formed (Online Figure  VIII, C ). If the same young, middle-aged, and old hCSCs experienced constant activation, 190, 215, and 305 mature myocytes were formed in 1 month, and 2300, 2600, and 3600 in 1 year, respectively ( Figure 6A ). These data, in combination with the number of functionally competent hCSCs in the heart (see Figure 3B ), allowed us to determine the agedependent changes in the rate of cardiomyocyte generation in women and men. During the course of life, the rate of myocyte formation increased by 2 500 000/10 g per year in females and 1 000 000/10 g per year in males ( Figure 6B ).
In the young, middle-aged, and old heart, myocyte volume was, respectively, 22 000, 23 000, and 23 000 m 3 in women and 23 000, 26 000, and 29 000 m 3 in men. 10 The number of cardiomyocytes per 10 g of myocardium was then obtained to compute the fraction of myocytes replaced per year. Annually, myocyte turnover involved 8%, 14%, and 31% of cells in young, middle-aged, and old women and 7%, 13%, and 18% of cells in young, middle-aged, and old men, respectively (Online Figure IX) . The average age of myocytes was 7 years in young, 3 years in middle-aged, and 2 years in the old female heart. Corresponding values in men were 8, 4, and 3 years (Online Figure X) .
Population Dynamics and Distribution of Myocyte Age
The model of population dynamics, which is based on the differential equation of age density function, 28 does not use the information related to the behavior and fate of hCSCs. It is based on the knowledge of the various classes of cardio- myocytes to define their different age. This parameter permits also the computation of myocyte turnover and the measurement of the average myocyte age at any point in time during the course of life. Thus, the hierarchical and population dynamics models provide complementary information and are expected to generate comparable data. The results on cycling and mitotic myocytes, together with the values of myocyte death, allowed us to compute the average birth date and distribution of ages of parenchymal cells in the female and male heart. Organ age inversely correlated with myocyte age in both genders: young hearts had older myocytes than senescent hearts. Moreover, the middle-aged and old female heart was composed of younger cells than the male heart. The average age of myocytes in young, middle-aged, and old women was 7, 3.5, and 2.5 years, respectively. Values in men were 8, 5, and 3 years (Online Figure XI) . The rate of myocyte renewal was 6%, 15%, and 37% per year in young, middle-aged, and old women and 5%, 13%, and 20% per year in young, middle-aged, and old men, respectively (Online Figure XII) .
These findings mimicked the results obtained independently with the model of hierarchically structured cell populations (see Online Figures IX and X) , so that the data generated by these 2 approaches were combined to yield the extent of myocyte replacement in the heart. Cell renewal accounted, respectively, for 7%, 15%, and 34% of myocytes in young, middle-aged, and old women and 6%, 13%, and 19% of myocytes in young, middle-aged, and old men ( Figure 6C) .
None of the myocytes present in the female and male heart at 20 years had the same age of the organ. The majority of cells (72%) were 3 to 12 years old; a small fraction (13%) was younger than 3 years and a similar proportion (15%) was older than 12 years. With the exception of a 23-year-old male heart in which 1.2% of myocytes were 23 years old, all parenchymal cells in the remaining 73 cases were younger than the organ and organism (Online Figure XI) .
A gender shift in the age distribution of myocytes became apparent at 50 years of age and increased with time ( Figure  7A ). In the oldest woman (102 years old) and man (104 years old), different proportions of young and old cells were found. Myocyte age in female and male heart varied from 0 to 9 years and 0 to 12 years, respectively ( Figure 7B ). Cells younger than 2 years comprised 37% and 29% of the myocyte population in women and men, respectively. Conversely, myocytes older than 5 years constituted 6% of the female and 20% of the male myocardium ( Figure 7B ).
Telomere Length in hCSCs and Myocytes
There was an apparent paradox between the increase in the number of senescent myocytes and the increase in myocyte renewal with aging. The older the organ the younger was, the age of the myocyte compartment. In an attempt to clarify this conundrum, telomere length was measured by Q-FISH in c-kit-positive hCSCs and myocytes of 20 hearts, 5 each from young and old women and men ( Figure 8A through 8C) . The objective was to determine whether aged hCSCs generated an old myocyte progeny.
The length of telomeres in hCSCs and myocytes showed a consistent pattern in each case. If hCSCs exhibited long telomeres, myocytes revealed comparable telomere length. Similarly, hCSCs with short telomeres were paralleled by myocytes with severe telomere attrition ( Figure 8D ). Telomeric shortening occurred with aging in hCSCs of both genders, although these changes were more dramatic in men than in women. Myocytes behaved in an identical manner ( Figure 8D ). Importantly, in all 10 old hearts, there was a small fraction of hCSCs and myocytes with telomeres of normal length, 8 to 12 kbp (Online Figure XIII) . Possibly, older hCSCs generated an older myocyte progeny, which rapidly acquired the senescent phenotype. This notion was supported by the documentation in the old hearts of myocyte precursors with telomeres Ͻ4 kbp (Online Figure XIV , A through C). These cell classes established a lineage relationship between aged hCSCs and aged myocytes.
These observations suggested that the time required by newly formed myocytes to become senescent varied with age. The number of years needed by a cardiomyocyte to express p16 INK4a was determined by combining the average age of cardiomyocytes with the percentage of cells positive for the senescence-associated protein. This time interval decreased progressively in aging women and men, although it was more rapid in male than in female myocytes. In a 20-year-old heart, nearly 14 years were necessary for myocytes to become p16 INK4a -positive, whereas, in a 90-year-old heart, myocytes reached the old phenotype in Ϸ2 years (Online Figure XIV, D) .
Discussion
The recognition that the human heart harbors resident multipotent hCSCs capable of forming cardiomyocytes and coronary vessels [2] [3] [4] [5] has posed the demanding question concerning the role of these cells in myocardial aging. 29 Results in the present study provide compelling evidence in favor of the notion that the aging myopathy is a stem cell disease. A progressive loss of telomeric DNA in hCSCs occurs with aging and, although the pool of functionally competent hCSCs expands with time and generates a larger myocyte progeny, the newly formed cardiomyocytes inherit short telomeres and rapidly reach the senescent cell phenotype. The expression of p16 INK4a becomes apparent, and apoptosis is markedly increased. Deficient hCSCs generate old cardiomyocytes, which, as shown in animal models, have severely depressed mechanical performance and alterations in calcium metabolism. 30, 31 Collectively, our data challenge current views on the mechanisms involved in the development of the aging myopathy in women and men. A decrease in myocyte turnover in the old heart has been claimed, 8 but our findings indicate that myocyte regeneration increases as a function of age, and the age of cardiomyocytes does not coincide with the age of the organ and organism. This discrepancy becomes more apparent in the senescent myocardium in which a large proportion of myocytes is Ϸ5 years old or younger in both women and men. The older the human heart, the younger is its myocyte compartment. From 19 to 104 years of age, essentially none of the myocytes present at birth is preserved in the young adult, middle-aged, and senescent heart. These findings question the contention that 50% of cardiomyocytes are not replaced during the entire lifespan in humans, 8 suggesting that a large proportion of cells survives and retains its function for more than 100 years. This rather static view of the heart is disputed here by offering a highly dynamic perspective of myocardial biology and aging.
The presence of hCSCs throughout the lifespan of the human heart is apparently at variance with the limited capacity of endogenous tissue repair after infarction. 12 This phenomenon has been interpreted as the unequivocal documentation of the inability of the adult heart to create cardiomyocytes. 1, [17] [18] [19] A possible explanation for this apparent paradox has been obtained in animal models in which dead stem cells have been found throughout the infarct, indicating that the fate of hCSCs is comparable to that of the other cells located in the ischemic region. 20 It might come as a surprise, but a similar event occurs in other solid and nonsolid organs including the skin, bone marrow, liver, intestine, and kidney. In all cases, occlusion of a supplying artery leads to scar formation mimicking cardiac pathology. 3, 20 
hCSCs and the Aging Heart
Results in the present study indicate that hCSC aging conditions myocardial aging; chronological age leads to telomeric attrition in hCSCs, which generate a progeny that rapidly attains the senescent phenotype. Daughter cells acquire the shortened telomeres of maternal hCSCs and, after a few rounds of division and terminal differentiation, express p16 INK4a in nearly 2 years. The pool of old cardiomyocytes progressively increases, defining the aging myopathy. Telomere length reflects the past replicative history and cumulative oxidative DNA damage occurring during the life cycle of the cell. 32 hCSC function is regulated by telomerase activity and telomere length. 3 Telomerase activity delays but cannot prevent telomere erosion, which is mediated by downregulation of telomerase, reactive oxygen species, and loss of telomere-related proteins. 12, 33 Shortening of telomeres beyond a critical length triggers cellular senescence, which corresponds to irreversible growth arrest in G 1 with loss of specialized functions, including cell proliferation, migration, and differentiation. Suggestive evidence in humans and genetically manipulated mice 34 -36 points to shortening of telomeres as a critical determinant of cellular senescence and, possibly, organ aging. In this regard, a lineage relationship was found between hCSCs with short telomeres and the formation of old myocytes. Although it is difficult to establish whether telomeric shortening is a consequence of aging or a primary event conditioning the aging myopathy, telomerase deletion is coupled with telomere shortening and the manifestation of a premature aging cardiac phenotype. 34 Of great interest, a pool of hCSCs with intact telomeres, 8 to 12 kbp, was found in the female and male heart at 90 to 104 years of age. This category of hCSCs with high growth reserve is expected to generate a young myocyte progeny within the senescent heart. Because each division of hCSCs results in the loss of Ϸ130 bp of telomeric DNA, 3 an extremely large number of cardiomyocytes can be formed by these cells, before critical telomeric shortening and growth arrest occur. 37 The heterogeneity in telomere length among hCSCs raises challenging questions. The possibility can be advanced that hCSCs with long telomeres are better equipped to sustain oxidative stress or are nested in well-protected areas of the myocardium. However, the variability in telomere length of hCSCs may be dictated by their different cycling history. In a manner similar to other tissue-specific stem cells, 37,38 the com- partment of hCSCs may be composed of a subset of quiescent cells with preserved telomere integrity and a pool of highly proliferating cells that maintain organ homeostasis but lose telomeric DNA at each round of division.
Alternatively, in the old heart, hCSCs with long telomeres may reflect a residual compartment of mother cells that retained the immortal DNA during division. If this hypothesis of stem cell growth is valid, 39, 40 stem cell division would be characterized by asymmetrical segregation of chromatids, so that 1 daughter cell contains only the old intact DNA templates, and the other daughter cell contains chromatids composed exclusively of the newly synthesized DNA strands. The process of nonrandom segregation of chromatids would attenuate the accumulation of spontaneous mutations and telomere attrition. 39 Whether these hCSCs can be selectively activated to repopulate the senescent heart with young, mechanically efficient cardiomyocytes remains an important unanswered question.
Gender and Myocardial Aging
Data in this study provide novel information on the superior ability of the female heart to sustain the multiple variables associated with the aging process and the development of the senescent myopathy. At all ages, the female heart is equipped with a larger pool of functionally competent hCSCs and younger myocytes than the male myocardium. The replicative potential is higher and telomeres are longer in female hCSCs than in male hCSCs. Animal studies have shown that the insulin-like growth factor (IGF)-1-IGF-1 receptor system is present in cardiac stem cells at very old age, 31 and overexpression of IGF-1 in cardiomyocytes prevents the manifestations of the senescent cardiac phenotype and heart failure. 41 Additionally, the IGF-1-IGF-1 receptor axis is enhanced in female myocytes, 42 and it may condition the favorable outcome of age in this gender. Importantly, premature cardiac aging appears to affect predominantly men than women. 43 Estrogens phosphorylate IGF-1 receptors, 44 mimicking the effects of IGF-1, a powerful inducer of CSC division, survival, and maintenance of telomere length. 31, 41 In postmenopausal women and throughout life in men, estrogen is synthesized in extragonadal organs including bone, cartilage, adipose tissue, skin, breast, and heart. 45 With aging, estrogen loses its circulating generalized function and works mainly at the local level as a paracrine, autocrine, or intracrine factor. Estrogen induces transcription of the catalytic subunit of the telomerase protein (TERT), because an estrogen response element is present in the TERT promoter. 46 Additional downstream effector pathways of estrogen involve the activation of phosphatidylinositol 3-kinase/Akt cascade, which exerts multiple beneficial effects on cardiac performance and biology. 47
Aging and Myocyte Turnover
The results of the present study indicate that myocyte regeneration in the physiologically aging heart takes place at previously unexpected levels in both women and men. In view of their similarity, the data obtained by the hierarchical model of myocyte renewal and those based on population dynamics were combined. In the female heart, myocyte replacement occurs at a rate of 10%, 14%, and 40% per year at 20, 60, and 100 years of age, respectively. Corresponding values in the male heart are 7%, 12%, and 32% per year, documenting that myocyte turnover involves a large and progressively increasing number of parenchymal cells with aging.
In the last 2 decades, several lines of evidence have been obtained in favor of the regeneration potential of the young, adult, and aged myocardium. 3, 10, 12, 14, 43, 48 Data on retrospective 14 C birth dating of myocytes have strengthened the notion that myocyte formation occurs in humans, but at a significantly lower rate than that reported here. 8 Hopefully, this work will resolve the long debate that has divided the scientific community in strong opponents and passionate supporters of the regenerative potential of the human heart, offering a more biologically valid understanding of cardiac homeostasis and repair. A common ground can now be found to translate this different perspective of cardiac biology into the development of novel strategies for the management of the human disease. However, the magnitude of the process, the effects of age on the extent of myocyte renewal, and the origin of newly formed cardiomyocytes is a matter of controversy.
These crucial issues have been answered in the present study, in which a series of integrated analyses have been performed. They included measurements of the number of hCSCs, the fraction of cycling hCSCs, and the length of their cell cycle to evaluate the rate of entry of hCSCs into the growth phase. Additionally, the number of forming myocytes at increasing levels of lineage specification was assessed. They involved myocyte progenitors, myocyte precursors, and amplifying myocytes to establish the number of divisions that 1 hCSC undergoes before the adult postmitotic cell phenotype is acquired. These parameters were introduced into the equation reflecting the growth kinetics of hierarchically structured cell populations, yielding a high degree of myocyte turnover, which increased further with age. From 20 to 100 years of age, the myocyte compartment was replaced completely 15 times in women and 11 times in men.
Myocyte Birth Dating
The striking differences between our results and the data derived from the integration of 14 C into the DNA of myocyte nuclei impose a careful evaluation of that published report. 8 Retrospective birth dating of human myocardium DNA by 14 C mirrors the incorporation of thymidine analogs in animal models, an analysis that has only been rarely possible in human beings and, thus far, has been restricted to the brain 49 and more recently to the heart. 14 An inherent limitation of 14 C birth dating is related to the need to introduce mathematical models with assumptions that affect the computed cell turnover values. 8 The scenario chosen presumed that the number of myocytes in the heart was constant and that cells turned over at a near constant rate. This form of invariant growth defines parenchyma in a steady state in which cell death is compensated by cell regeneration in young healthy individuals. However, this steady-state scenario poorly represents the biology of aging in men where nearly 64ϫ10 6 cardiomyocytes are lost per year. Furthermore, because women do not lose cardiomyocytes as they age like men, 10 different models should be used to reflect the changing cell popula-tions. Importantly, myocyte number increases postnatally, 14, 50 and cell loss typically occurs with cardiac diseases. 9 These limitations were avoided in the present study by evaluating a large number of nonpathologic aging hearts of both sexes. In contrast to the single determination of 14 C made in the earlier report, 8 multiple variables were measured and 2 distinct mathematical models were used. In both cases, the data concurred and were consistent with previous results. 14, 20 Another problem with the previous work involves the use of troponin I expression as a marker for the isolation of a representative pool of myocyte nuclei. However, the presence of troponin I identifies almost exclusively a population of p16 INK4a -positive senescent cells that exhibit marked alterations in the permeability of nuclear pore complexes. 14 Additionally, the percentage of p16 INK4a -positive myocytes varies dramatically with age and cardiac diseases. 12, 43 The failure to directly measure the 14 C content of nonmyocytes and the unrealistically high myocyte fraction varying from 29% to 60% of the cardiac cell pool, although accounting for Ϸ20% of the cells, 1 obscure the nonspecificity of the nuclear marker used to sort myocytes. Data from a small number of samples were used to generate a model despite nonphysical implications of the nonmyocyte population. In contrast, we used multiple markers of cell turnover in a large number of healthy hearts spanning a large age range to measure and model much higher cell turnover.
Limitations
Three potential confounding variables must be acknowledged. Measurements of myocyte growth and death have been based on the analysis of myocyte nuclei, which were considered indicative of the properties of the cells. In the human heart, nearly 80% of myocytes are mononucleated and only Ϸ20% are binucleated, and this proportion does not change with aging, as shown here and previously, 26 excluding its possible influence on the computed data. The 2 mathematical models used required some assumptions, although a significant amount of primary data has been included, and both methods independently provided comparable results. A statement of caution must be made concerning the length of the cell cycle; this parameter was measured in vitro and claimed to be similar in vivo. Additionally, the duration of the cell cycle and the time for the completion of apoptotic cell death were considered to remain relatively constant with age. 
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The recognition that the human heart harbors resident multipotent hCSCs capable of forming cardiomyocytes and coronary vessels has posed a demanding question concerning the role of these cells in myocardial aging. We provide evidence in favor of the notion that the myopathy of aging leads to stem cell senescence. A progressive loss of telomeric DNA in hCSCs occurs with aging and, although the pool of functionally competent hCSCs expands with time and generates a larger myocyte progeny, the newly formed cardiomyocytes inherit short telomeres and rapidly reach the senescent cell phenotype. The expression of p16 INK4a becomes apparent and apoptosis is markedly increased. Aged hCSCs appear to generate "old" myocytes that may have severely depressed mechanical performance and alterations in calcium metabolism, contributing to the manifestations of heart failure in the elderly.
